Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms
Authors
Keywords
-
Journal
ENDOCRINE PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-07
DOI
10.1007/s12022-020-09657-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
- (2019) Loredana Puca et al. Science Translational Medicine
- Targeting DLL3 in neuroendocrine prostate cancer
- (2019) Clemens Thoma Nature Reviews Urology
- DLL3: an emerging target in small cell lung cancer
- (2019) Dwight H. Owen et al. Journal of Hematology & Oncology
- Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small Cell Lung Cancer: Results From the Phase II TRINITY Study
- (2019) Daniel Morgensztern et al. CLINICAL CANCER RESEARCH
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- Current Perspectives in Cancer Immunotherapy
- (2019) Theodoulakis Christofi et al. Cancers
- Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
- (2019) N. Alcala et al. Nature Communications
- Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs
- (2018) Stefano Cavalieri et al. CANCER TREATMENT REVIEWS
- Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models
- (2018) Kenta Kawasaki et al. Disease Models & Mechanisms
- Open issues on G3 neuroendocrine neoplasms: back to the future
- (2018) Maria Chiara Zatelli et al. ENDOCRINE-RELATED CANCER
- The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
- (2018) Halfdan Sorbye et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer
- (2018) Kentaro Tanaka et al. LUNG CANCER
- Treatment options for PNET liver metastases: a systematic review
- (2018) Giuseppe Nigri et al. World Journal of Surgical Oncology
- Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
- (2018) Julie George et al. Nature Communications
- Grading of Neuroendocrine Carcinomas: Correlation of 68Ga-PET/CT Scan with Tissue Biomarkers
- (2018) Chiara Liverani et al. DISEASE MARKERS
- Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives
- (2018) Aura D. Herrera-Martínez et al. DRUGS
- ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
- (2018) Chang S. Chan et al. Nature Communications
- Current best practice in the management of neuroendocrine tumors
- (2018) Marina Tsoli et al. Therapeutic Advances in Endocrinology and Metabolism
- Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way
- (2017) Lucas Leite Cunha et al. ENDOCRINE-RELATED CANCER
- Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases
- (2017) Aatur D Singhi et al. HISTOPATHOLOGY
- Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
- (2017) Charles M Rudin et al. LANCET ONCOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification
- (2017) Aurel Perren et al. NEUROENDOCRINOLOGY
- Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading
- (2017) Elisabetta Cavalcanti et al. Cell Death & Disease
- Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
- (2017) Bryan Oronsky et al. NEOPLASIA
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas
- (2016) Laura H. Tang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
- (2016) Dik J. Kwekkeboom et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
- (2016) R. Garcia-Carbonero et al. NEUROENDOCRINOLOGY
- Notch signaling and Tp53/RB1 pathway in pulmonary neuroendocrine tumorigenesis
- (2016) Takaaki Ito et al. Translational Cancer Research
- Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas
- (2015) L. H. Tang et al. CLINICAL CANCER RESEARCH
- NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
- (2015) Lydia Meder et al. INTERNATIONAL JOURNAL OF CANCER
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
- (2015) Laura R. Saunders et al. Science Translational Medicine
- First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
- (2015) Alberto Bongiovanni et al. OncoTargets and Therapy
- Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
- (2012) H. Sorbye et al. ANNALS OF ONCOLOGY
- New treatment strategies in advanced neuroendocrine tumours
- (2011) Thomas Walter et al. DIGESTIVE AND LIVER DISEASE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started